"Thyroid Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the THYROID GLAND.
| Descriptor ID |
D013964
|
| MeSH Number(s) |
C04.588.322.894 C04.588.443.915 C19.344.894 C19.874.788
|
| Concept/Terms |
Thyroid Neoplasms- Thyroid Neoplasms
- Neoplasm, Thyroid
- Thyroid Neoplasm
- Neoplasms, Thyroid
Thyroid Carcinoma- Thyroid Carcinoma
- Carcinoma, Thyroid
- Carcinomas, Thyroid
- Thyroid Carcinomas
- Cancer of Thyroid
- Thyroid Cancers
- Thyroid Cancer
- Cancer, Thyroid
- Cancers, Thyroid
- Cancer of the Thyroid
Thyroid Adenoma- Thyroid Adenoma
- Adenoma, Thyroid
- Adenomas, Thyroid
- Thyroid Adenomas
|
Below are MeSH descriptors whose meaning is more general than "Thyroid Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Thyroid Neoplasms".
This graph shows the total number of publications written about "Thyroid Neoplasms" by people in this website by year, and whether "Thyroid Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 1 | 1 |
| 1994 | 3 | 0 | 3 |
| 1995 | 3 | 1 | 4 |
| 1996 | 2 | 0 | 2 |
| 1997 | 2 | 0 | 2 |
| 1998 | 2 | 0 | 2 |
| 2001 | 2 | 0 | 2 |
| 2002 | 3 | 1 | 4 |
| 2003 | 3 | 0 | 3 |
| 2004 | 1 | 1 | 2 |
| 2005 | 5 | 0 | 5 |
| 2006 | 4 | 1 | 5 |
| 2007 | 5 | 0 | 5 |
| 2008 | 5 | 0 | 5 |
| 2009 | 4 | 2 | 6 |
| 2010 | 7 | 2 | 9 |
| 2011 | 11 | 3 | 14 |
| 2012 | 11 | 1 | 12 |
| 2013 | 14 | 1 | 15 |
| 2014 | 19 | 2 | 21 |
| 2015 | 14 | 1 | 15 |
| 2016 | 18 | 0 | 18 |
| 2017 | 12 | 1 | 13 |
| 2018 | 20 | 0 | 20 |
| 2019 | 9 | 0 | 9 |
| 2020 | 15 | 3 | 18 |
| 2021 | 10 | 0 | 10 |
| 2022 | 8 | 1 | 9 |
| 2023 | 6 | 0 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thyroid Neoplasms" by people in Profiles.
-
Population-Based Genomic RET Screening-Reply. JAMA Otolaryngol Head Neck Surg. 2023 Sep 01; 149(9):853.
-
A multicenter, open-label, randomized, phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancer. Ann Oncol. 2023 08; 34(8):714-722.
-
Association of DNA Promoter Methylation and BRAF Mutation in Thyroid Cancer. Curr Oncol. 2023 03 02; 30(3):2978-2996.
-
Medullary Thyroid Carcinoma and Population Screening-The Promise and Pitfalls of Genetic Testing. JAMA Otolaryngol Head Neck Surg. 2023 03 01; 149(3):202-203.
-
High-Grade Non-Anaplastic Thyroid Carcinomas of Follicular Cell Origin: A Review of Poorly Differentiated and High-Grade Differentiated Carcinomas. Endocr Pathol. 2023 Mar; 34(1):34-47.
-
Cancer Risk Associated With PTEN Pathogenic Variants Identified Using Multigene Hereditary Cancer Panel Testing. JCO Precis Oncol. 2023 01; 7:e2200415.
-
To Freeze or Not to Freeze? Recommendations for Intraoperative Examination and Gross Prosection of Thyroid Glands. Surg Pathol Clin. 2023 Mar; 16(1):15-26.
-
Evaluating new treatments for anaplastic thyroid cancer. Expert Rev Anticancer Ther. 2022 Nov; 22(11):1239-1247.
-
The Significance of RAS-Like Mutations and MicroRNA Profiling in Predicting Malignancy in Thyroid Biopsy Specimens. Endocr Pathol. 2022 Dec; 33(4):446-456.
-
Graves' disease and papillary thyroid carcinoma: case report and literature review of a single academic center. BMC Endocr Disord. 2022 Aug 09; 22(1):199.